BAL PHARMA LTD.

BAL PHARMA LTD. - Updates

Download	< Back
04 Apr 2017
Sub: Exercise of option for submission of financial results. Ref: Regulation 33 (3)(b)(1) of SEBI (LODR) Regulations, 2015. With reference to the above cited subject and reference, we would like to inform the exchange that the Company has opted to submit only standalone financial statements to the exchange for the financial year 2017.18. However, both standalone and consolidated financial statements of the Company will be made available on our website i.e www.balpharma.com , as per the provisions of Regulation 33 of SEBI(LODR) Regulations, 2015. Please take this intimation on record. Thanking You.
View all announcements for BAL PHARMA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us